Lv7
3940 积分 2022-04-14 加入
Long term survival in patients with hepatocellular carcinoma directly invading the gastrointestinal tract: Case reports and literature review
7天前
已完结
Gastrointestinal Tract Involvement in Hepatocellular Carcinoma: Clinical, Radiological and Endoscopic Studies
7天前
已完结
Clinicopathological Study of Gastric Metastases
7天前
已完结
Gastrointestinal metastasis in hepatocellular carcinoma: Radiological and endoscopic studies of 11 cases
7天前
已完结
Poor Tolerability of Lenvatinib in Elderly Patients with Advanced Hepatocellular Carcinoma after Disease Progression following First-Line Atezolizumab Plus Bevacizumab: A Multicenter Study
14天前
已关闭
Lenvatinib versus sorafenib second-line therapy in patients with hepatocellular carcinoma progressed to atezolizumab plus bevacizumab: a retrospective real-world study
14天前
已完结
Efficacy and Safety of Durvalumab/Tremelimumab in Unresectable Hepatocellular Carcinoma as Immune Checkpoint Inhibitor Rechallenge Following Atezolizumab/Bevacizumab Treatment
14天前
已完结
Treatment response to durvalumab plus tremelimumab after progression with previous immune checkpoint inhibitor in unresectable hepatocellular carcinoma
14天前
已完结
Advancements in second-line treatment research for hepatocellular carcinoma
14天前
已完结
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment
14天前
已完结
皖公网安备34019202002308
